Leica Biosystems, a Danaher company, has officially acquired StatLab Medical Products from Linden Capital Partners and Audax Private Equity, aiming to advance precision oncology, according to an announcement.

By bringing together complementary capabilities across the pathology workflow, Leica Biosystems is bolstering its comprehensive end-to-end lab portfolio, from specimen collection and preparation through advanced staining, digital imaging and AI-enabled diagnosis. This expanded offering is designed to help pathology laboratories optimize critical histology workflows, reduce variation and move from sample to answer with greater speed, consistency and confidence.

Ultimately, this expanded offering can help clinicians deliver more timely answers for the patients who depend on them.

Visit Leica Biosystems for more information